Cross Country Healthcare, Inc. (CCRN)
USD 14.38
(0.35%)
USD 14.38
(0.35%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 205.92 Million USD | -58.03% |
| 2022 | 490.62 Million USD | 12.71% |
| 2021 | 435.28 Million USD | 115.42% |
| 2020 | 202.06 Million USD | -7.68% |
| 2019 | 218.87 Million USD | 4.82% |
| 2018 | 208.8 Million USD | -9.2% |
| 2017 | 229.96 Million USD | -2.79% |
| 2016 | 236.57 Million USD | 5.26% |
| 2015 | 224.75 Million USD | 15.38% |
| 2014 | 194.8 Million USD | 176.18% |
| 2013 | 70.53 Million USD | -27.14% |
| 2012 | 96.8 Million USD | 11.77% |
| 2011 | 86.61 Million USD | -15.25% |
| 2010 | 102.19 Million USD | -7.53% |
| 2009 | 110.51 Million USD | -42.39% |
| 2008 | 191.82 Million USD | 32.41% |
| 2007 | 144.87 Million USD | 12.15% |
| 2006 | 129.17 Million USD | 5.56% |
| 2005 | 122.37 Million USD | 11.63% |
| 2004 | 109.62 Million USD | -28.91% |
| 2003 | 154.2 Million USD | 71.78% |
| 2002 | 89.76 Million USD | -2.48% |
| 2001 | 92.05 Million USD | -52.62% |
| 2000 | 194.28 Million USD | 1.75% |
| 1999 | 190.95 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 180.24 Million USD | -12.47% |
| 2024 Q2 | 163.82 Million USD | -9.11% |
| 2023 FY | 205.92 Million USD | -58.03% |
| 2023 Q3 | 238.07 Million USD | -20.85% |
| 2023 Q1 | 468.61 Million USD | -4.49% |
| 2023 Q4 | 205.92 Million USD | -13.51% |
| 2023 Q2 | 300.78 Million USD | -35.81% |
| 2022 Q1 | 560.36 Million USD | 28.74% |
| 2022 Q2 | 528.15 Million USD | -5.75% |
| 2022 FY | 490.62 Million USD | 12.71% |
| 2022 Q4 | 490.62 Million USD | 6.7% |
| 2022 Q3 | 459.8 Million USD | -12.94% |
| 2021 Q4 | 435.28 Million USD | 43.36% |
| 2021 Q3 | 303.62 Million USD | 0.7% |
| 2021 Q2 | 301.5 Million USD | 12.22% |
| 2021 FY | 435.28 Million USD | 115.42% |
| 2021 Q1 | 268.67 Million USD | 32.97% |
| 2020 Q3 | 208.91 Million USD | 2.85% |
| 2020 Q4 | 202.06 Million USD | -3.28% |
| 2020 FY | 202.06 Million USD | -7.68% |
| 2020 Q1 | 225.57 Million USD | 3.06% |
| 2020 Q2 | 203.12 Million USD | -9.95% |
| 2019 Q1 | 225.42 Million USD | 7.96% |
| 2019 Q2 | 232.28 Million USD | 3.04% |
| 2019 Q4 | 218.87 Million USD | -4.98% |
| 2019 Q3 | 230.34 Million USD | -0.83% |
| 2019 FY | 218.87 Million USD | 4.82% |
| 2018 FY | 208.8 Million USD | -9.2% |
| 2018 Q4 | 208.8 Million USD | -4.95% |
| 2018 Q3 | 219.68 Million USD | -1.19% |
| 2018 Q2 | 222.33 Million USD | -0.61% |
| 2018 Q1 | 223.69 Million USD | -2.73% |
| 2017 FY | 229.96 Million USD | -2.79% |
| 2017 Q4 | 229.96 Million USD | -7.01% |
| 2017 Q3 | 247.3 Million USD | 36.75% |
| 2017 Q2 | 180.84 Million USD | 4.84% |
| 2017 Q1 | 172.5 Million USD | -27.08% |
| 2016 Q3 | 205.49 Million USD | 2.7% |
| 2016 Q2 | 200.08 Million USD | 0.42% |
| 2016 FY | 236.57 Million USD | 5.26% |
| 2016 Q4 | 236.57 Million USD | 15.13% |
| 2016 Q1 | 199.25 Million USD | -11.34% |
| 2015 Q4 | 224.75 Million USD | 13.68% |
| 2015 Q2 | 195.1 Million USD | -2.41% |
| 2015 FY | 224.75 Million USD | 15.38% |
| 2015 Q3 | 197.7 Million USD | 1.33% |
| 2015 Q1 | 199.92 Million USD | 2.63% |
| 2014 Q2 | 184.13 Million USD | 84.9% |
| 2014 Q1 | 99.58 Million USD | 41.19% |
| 2014 Q3 | 186.43 Million USD | 1.25% |
| 2014 Q4 | 194.8 Million USD | 4.49% |
| 2014 FY | 194.8 Million USD | 176.18% |
| 2013 Q3 | 62.72 Million USD | -0.41% |
| 2013 Q2 | 62.98 Million USD | -7.59% |
| 2013 Q1 | 68.15 Million USD | -29.59% |
| 2013 FY | 70.53 Million USD | -27.14% |
| 2013 Q4 | 70.53 Million USD | 12.45% |
| 2012 Q1 | 85.11 Million USD | -1.73% |
| 2012 FY | 96.8 Million USD | 11.77% |
| 2012 Q2 | 82.77 Million USD | -2.75% |
| 2012 Q4 | 96.8 Million USD | 16.42% |
| 2012 Q3 | 83.15 Million USD | 0.46% |
| 2011 Q4 | 86.6 Million USD | -8.68% |
| 2011 Q1 | 96.51 Million USD | -5.56% |
| 2011 Q3 | 94.84 Million USD | -1.82% |
| 2011 Q2 | 96.6 Million USD | 0.09% |
| 2011 FY | 86.61 Million USD | -15.25% |
| 2010 Q1 | 106.82 Million USD | -3.34% |
| 2010 FY | 102.19 Million USD | -7.53% |
| 2010 Q3 | 105.28 Million USD | 1.15% |
| 2010 Q4 | 102.19 Million USD | -2.93% |
| 2010 Q2 | 104.08 Million USD | -2.56% |
| 2009 Q3 | 124.34 Million USD | -17.41% |
| 2009 FY | 110.51 Million USD | -42.39% |
| 2009 Q4 | 110.51 Million USD | -11.12% |
| 2009 Q2 | 150.56 Million USD | -16.74% |
| 2009 Q1 | 180.83 Million USD | -5.73% |
| 2008 Q4 | 191.82 Million USD | -28.58% |
| 2008 Q2 | 140.83 Million USD | -6.09% |
| 2008 Q1 | 149.97 Million USD | 3.52% |
| 2008 FY | 191.82 Million USD | 32.41% |
| 2008 Q3 | 268.59 Million USD | 90.71% |
| 2007 FY | 144.87 Million USD | 12.15% |
| 2007 Q2 | 126.53 Million USD | -2.19% |
| 2007 Q4 | 144.87 Million USD | -2.65% |
| 2007 Q3 | 148.81 Million USD | 17.61% |
| 2007 Q1 | 129.37 Million USD | 0.15% |
| 2006 FY | 129.17 Million USD | 5.56% |
| 2006 Q4 | 129.17 Million USD | 2.45% |
| 2006 Q3 | 126.08 Million USD | 30.58% |
| 2006 Q2 | 96.55 Million USD | -15.23% |
| 2006 Q1 | 113.9 Million USD | -6.92% |
| 2005 Q4 | 122.37 Million USD | -1.94% |
| 2005 Q3 | 124.79 Million USD | -1.19% |
| 2005 Q1 | 110.32 Million USD | 0.64% |
| 2005 Q2 | 126.3 Million USD | 14.49% |
| 2005 FY | 122.37 Million USD | 11.63% |
| 2004 FY | 109.62 Million USD | -28.91% |
| 2004 Q3 | 122.44 Million USD | -7.17% |
| 2004 Q2 | 131.9 Million USD | -10.03% |
| 2004 Q1 | 146.61 Million USD | -4.92% |
| 2004 Q4 | 109.62 Million USD | -10.48% |
| 2003 Q1 | 77.85 Million USD | -13.27% |
| 2003 Q3 | 172.77 Million USD | -3.14% |
| 2003 FY | 154.2 Million USD | 71.78% |
| 2003 Q2 | 178.36 Million USD | 129.1% |
| 2003 Q4 | 154.2 Million USD | -10.75% |
| 2002 FY | 89.76 Million USD | -2.48% |
| 2002 Q4 | 89.76 Million USD | -11.35% |
| 2002 Q3 | 101.26 Million USD | 2.14% |
| 2002 Q1 | 97.83 Million USD | 6.28% |
| 2002 Q2 | 99.14 Million USD | 1.34% |
| 2001 Q4 | 92.05 Million USD | -60.32% |
| 2001 FY | 92.05 Million USD | -52.62% |
| 2001 Q3 | 232.01 Million USD | 0.0% |
| 2000 FY | 194.28 Million USD | 1.75% |
| 1999 FY | 190.95 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 91.667% |
| Addus HomeCare Corporation | 317.73 Million USD | 35.189% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -58.941% |
| Amedisys, Inc. | 940.38 Million USD | 78.102% |
| American Oncology Network, Inc. | 368.72 Million USD | 44.153% |
| Astrana Health, Inc. | 522.59 Million USD | 60.596% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 88.33% |
| IMAC Holdings, Inc. | 1.89 Million USD | -10756.584% |
| biote Corp. | 191.84 Million USD | -7.341% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -185.008% |
| COMPASS Pathways plc | 50.24 Million USD | -309.856% |
| DocGo Inc. | 185.28 Million USD | -11.141% |
| The Ensign Group, Inc. | 2.68 Billion USD | 92.317% |
| Healthcare Services Group, Inc. | 346.56 Million USD | 40.582% |
| InnovAge Holding Corp. | 247.85 Million USD | 16.917% |
| Assure Holdings Corp. | 22.84 Million USD | -801.239% |
| The Joint Corp. | 62.37 Million USD | -230.118% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 74.396% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -5303.181% |
| ModivCare Inc. | 1.61 Billion USD | 87.218% |
| NewGenIvf Group Limited | 1.24 Million USD | -16487.578% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -1761.212% |
| Option Care Health, Inc. | 1.9 Billion USD | 89.2% |
| P3 Health Partners Inc. | 427.3 Million USD | 51.809% |
| P3 Health Partners Inc. | 427.3 Million USD | 51.809% |
| The Pennant Group, Inc. | 394.17 Million USD | 47.758% |
| Surgery Partners, Inc. | 3.65 Billion USD | 94.369% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -22527.221% |
| Talkspace, Inc. | 23.57 Million USD | -773.485% |
| Talkspace, Inc. | 23.57 Million USD | -773.485% |
| The Oncology Institute, Inc. | 162.39 Million USD | -26.806% |
| The Oncology Institute, Inc. | 162.39 Million USD | -26.806% |